459 related articles for article (PubMed ID: 25700737)
1. A novel mechanism of autophagic cell death in dystrophic muscle regulated by P2RX7 receptor large-pore formation and HSP90.
Young CN; Sinadinos A; Lefebvre A; Chan P; Arkle S; Vaudry D; Gorecki DC
Autophagy; 2015; 11(1):113-30. PubMed ID: 25700737
[TBL] [Abstract][Full Text] [Related]
2. Zidovudine ameliorates pathology in the mouse model of Duchenne muscular dystrophy via P2RX7 purinoceptor antagonism.
Al-Khalidi R; Panicucci C; Cox P; Chira N; Róg J; Young CNJ; McGeehan RE; Ambati K; Ambati J; Zabłocki K; Gazzerro E; Arkle S; Bruno C; Górecki DC
Acta Neuropathol Commun; 2018 Apr; 6(1):27. PubMed ID: 29642926
[TBL] [Abstract][Full Text] [Related]
3. P2RX7 purinoceptor: a therapeutic target for ameliorating the symptoms of duchenne muscular dystrophy.
Sinadinos A; Young CN; Al-Khalidi R; Teti A; Kalinski P; Mohamad S; Floriot L; Henry T; Tozzi G; Jiang T; Wurtz O; Lefebvre A; Shugay M; Tong J; Vaudry D; Arkle S; doRego JC; Górecki DC
PLoS Med; 2015 Oct; 12(10):e1001888. PubMed ID: 26461208
[TBL] [Abstract][Full Text] [Related]
4. P2X7 purinoceptor alterations in dystrophic mdx mouse muscles: relationship to pathology and potential target for treatment.
Young CN; Brutkowski W; Lien CF; Arkle S; Lochmüller H; Zabłocki K; Górecki DC
J Cell Mol Med; 2012 May; 16(5):1026-37. PubMed ID: 21794079
[TBL] [Abstract][Full Text] [Related]
5. Impact of P2RX7 ablation on the morphological, mechanical and tissue properties of bones in a murine model of duchenne muscular dystrophy.
Mohamad NS; Sinadinos A; Górecki DC; Zioupos P; Tong J
J Biomech; 2016 Oct; 49(14):3444-3451. PubMed ID: 27663621
[TBL] [Abstract][Full Text] [Related]
6. Mitophagy regulates mitochondrial network signaling, oxidative stress, and apoptosis during myoblast differentiation.
Baechler BL; Bloemberg D; Quadrilatero J
Autophagy; 2019 Sep; 15(9):1606-1619. PubMed ID: 30859901
[TBL] [Abstract][Full Text] [Related]
7. Increased susceptibility to ATP via alteration of P2X receptor function in dystrophic mdx mouse muscle cells.
Yeung D; Zablocki K; Lien CF; Jiang T; Arkle S; Brutkowski W; Brown J; Lochmuller H; Simon J; Barnard EA; Górecki DC
FASEB J; 2006 Apr; 20(6):610-20. PubMed ID: 16581969
[TBL] [Abstract][Full Text] [Related]
8. Perturbation of PI3K/Akt signaling affected autophagy modulation in dystrophin-deficient myoblasts.
Yazid MD; Hung-Chih C
Cell Commun Signal; 2021 Oct; 19(1):105. PubMed ID: 34706731
[TBL] [Abstract][Full Text] [Related]
9. Dystrophic mdx mouse myoblasts exhibit elevated ATP/UTP-evoked metabotropic purinergic responses and alterations in calcium signalling.
Róg J; Oksiejuk A; Gosselin MRF; Brutkowski W; Dymkowska D; Nowak N; Robson S; Górecki DC; Zabłocki K
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1138-1151. PubMed ID: 30684640
[TBL] [Abstract][Full Text] [Related]
10. Store-operated calcium entry contributes to abnormal Ca²⁺ signalling in dystrophic mdx mouse myoblasts.
Onopiuk M; Brutkowski W; Young C; Krasowska E; Róg J; Ritso M; Wojciechowska S; Arkle S; Zabłocki K; Górecki DC
Arch Biochem Biophys; 2015 Mar; 569():1-9. PubMed ID: 25659883
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of Muscle T Regulatory Cells and Improvement of Muscular Dystrophic Process in mdx Mice by Blockade of Extracellular ATP/P2X Axis.
Gazzerro E; Baldassari S; Assereto S; Fruscione F; Pistorio A; Panicucci C; Volpi S; Perruzza L; Fiorillo C; Minetti C; Traggiai E; Grassi F; Bruno C
Am J Pathol; 2015 Dec; 185(12):3349-60. PubMed ID: 26465071
[TBL] [Abstract][Full Text] [Related]
12. The Role of P2X7 Purinoceptors in the Pathogenesis and Treatment of Muscular Dystrophies.
Zabłocki K; Górecki DC
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298386
[TBL] [Abstract][Full Text] [Related]
13. Altered mitogen-activated protein kinase signaling in dystrophic (mdx) muscle.
Smythe GM; Forwood JK
Muscle Nerve; 2012 Sep; 46(3):374-83. PubMed ID: 22907228
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor type-β inhibits Mas receptor expression in fibroblasts but not in myoblasts or differentiated myotubes; Relevance to fibrosis associated to muscular dystrophies.
Cofre C; Acuña MJ; Contreras O; Morales MG; Riquelme C; Cabello-Verrugio C; Brandan E
Biofactors; 2015; 41(2):111-20. PubMed ID: 25809912
[TBL] [Abstract][Full Text] [Related]
15. AMPK activation stimulates autophagy and ameliorates muscular dystrophy in the mdx mouse diaphragm.
Pauly M; Daussin F; Burelle Y; Li T; Godin R; Fauconnier J; Koechlin-Ramonatxo C; Hugon G; Lacampagne A; Coisy-Quivy M; Liang F; Hussain S; Matecki S; Petrof BJ
Am J Pathol; 2012 Aug; 181(2):583-92. PubMed ID: 22683340
[TBL] [Abstract][Full Text] [Related]
16. P2X7 purinoceptor as a therapeutic target in muscular dystrophies.
Górecki DC
Curr Opin Pharmacol; 2019 Aug; 47():40-45. PubMed ID: 30901735
[TBL] [Abstract][Full Text] [Related]
17. Adenylosuccinic acid therapy ameliorates murine Duchenne Muscular Dystrophy.
Timpani CA; Goodman CA; Stathis CG; White JD; Mamchaoui K; Butler-Browne G; Gueven N; Hayes A; Rybalka E
Sci Rep; 2020 Jan; 10(1):1125. PubMed ID: 31980663
[TBL] [Abstract][Full Text] [Related]
18. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
19. Dystrophin: The dead calm of a dogma.
Górecki DC
Rare Dis; 2016; 4(1):e1153777. PubMed ID: 27141413
[TBL] [Abstract][Full Text] [Related]
20. Distinct roles of TRAF6 at early and late stages of muscle pathology in the mdx model of Duchenne muscular dystrophy.
Hindi SM; Sato S; Choi Y; Kumar A
Hum Mol Genet; 2014 Mar; 23(6):1492-505. PubMed ID: 24163132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
